Industry Groups Need FDA Input On Antibacterial Ingredient Studies
This article was originally published in The Tan Sheet
Executive Summary
The Personal Care Products Council and American Cleaning Institute say industry needs FDA input on study designs and more time to study benzethonium and benzalkonium chloride in consumer antimicrobial wash products. FDA’s commitment under a 2013 consent decree to publish a monograph for triclosan use by September 2016 should not influence the GRASE status of other ingredients, the groups say.
You may also be interested in...
Consent Decree Orders FDA Action On Triclosan OTC Monographs
A Nov. 21 consent decree sets multiple deadlines over a five-year period to make FDA finalize its OTC topical antimicrobial drug products monograph with respect to triclosan. Under one deadline of note to triclosan product makers, the agency must publish a tentative final monograph for consumer antiseptic hand wash products by Dec. 16, with a final monograph due by Sept. 15, 2016.
FDA Says Industry Has Work Left To Do To Make Antiviral Claims For Topicals
FDA rejects a citizen petition seeking antiviral labeling for OTC products covered by the Healthcare Antiseptic Drug Products monograph
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.